CERUS CORP
10-Q, EX-27.1, 2000-08-08
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CERUS CORP, 10-Q, 2000-08-08
Next: LINCOLN LIFE & ANNUITY VAR ANN SEP ACCT L GROUP VAR ANN II, 485BPOS, 2000-08-08



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          35,512
<SECURITIES>                                    14,816
<RECEIVABLES>                                      162
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                50,736
<PP&E>                                           4,222
<DEPRECIATION>                                   3,182
<TOTAL-ASSETS>                                  51,901
<CURRENT-LIABILITIES>                           10,453
<BONDS>                                              0
                            5,000
                                      9,496
<COMMON>                                            13
<OTHER-SE>                                      26,843
<TOTAL-LIABILITY-AND-EQUITY>                    51,901
<SALES>                                              0
<TOTAL-REVENUES>                                 1,017
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                18,629
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                               (15,996)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (15,996)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (15,996)
<EPS-BASIC>                                     (1.28)
<EPS-DILUTED>                                   (1.28)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission